<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title>Inbox Robot: Eli Lilly News</title>
<link>http://www.inboxrobot.com/news/eli-lilly</link><description>Constantly updated news and information about a variety of topics.</description><item>
<title>Sentencing date set for Scruggs&#39; former lawyer - 11/18</title>
<link>http://www.inboxrobot.com/news.php?fid=199328678</link>
<pubDate>19 Nov 2008 22:31 GMT</pubDate>
<description>
...  disputed by state Auditor Stacey Pickering. The other, the State&#39;s case against pharmaceutical giant Eli Lilly &amp; Co., is ongoing. Langston was relieved of his duties by Hood after he  ...
</description>
</item><item>
<title>US panel urges study of antipsychotics in children</title>
<link>http://www.inboxrobot.com/news.php?fid=199326930</link>
<pubDate>19 Nov 2008 22:30 GMT</pubDate>
<description>
...  of the safety of Johnson &amp; Johnson&#39;s (JNJ.N: ) drug Risperdal, or risperidone, and Eli Lilly and Co&#39;s (LLY.N: ) Zyprexa, or olanzapine, the panel on Tuesday unanimously requested more  ...
</description>
</item><item>
<title>IMPAX Sued Based on ANDA for Generic Cymbalta</title>
<link>http://www.inboxrobot.com/news.php?fid=199325519</link>
<pubDate>19 Nov 2008 22:27 GMT</pubDate>
<description>
... IMPAX Laboratories, Inc. today announced Eli Lilly and Company has filed suit alleging infringement U.S. Patent No. 5,023,269 (the &amp;ldquo;&#39;269 patent&amp;rdquo;)  ...
</description>
</item><item>
<title>SSRI Antidepressants Pushers</title>
<link>http://www.inboxrobot.com/news.php?fid=199321129</link>
<pubDate>19 Nov 2008 21:55 GMT</pubDate>
<description>
...  Grassley. Dr Wagner also failed to disclose earnings of more than $11,000 from Prozac-maker Eli Lilly in 2002. On August 18, 2008, the Dallas Morning News reported that a state  ...
</description>
</item><item>
<title>AstraZeneca&#39;s Generic Foe</title>
<link>http://www.inboxrobot.com/news.php?fid=199319656</link>
<pubDate>19 Nov 2008 21:31 GMT</pubDate>
<description>
...  lung cancer patients. The drug failed to meet the same goal when combined with Eli Lilly&#39;s Alimta and in a head-to-head study with Tarceva, which is made by ...
</description>
</item><item>
<title>Depressing News for Drugmakers</title>
<link>http://www.inboxrobot.com/news.php?fid=199318586</link>
<pubDate>19 Nov 2008 21:30 GMT</pubDate>
<description>
...  for these branded drugs, the study also included antidepressants available as generics, such as Eli Lilly&#39;s Prozac, Wyeth &#39;s Serzone. Since they&#39;re usually available more cheaply, doctors may continue to  ...
</description>
</item><item>
<title>European patent office restores breast cancer gene patent</title>
<link>http://www.inboxrobot.com/news.php?fid=199315635</link>
<pubDate>19 Nov 2008 21:25 GMT</pubDate>
<description>
...  an end to a 14-year court battle in Europe pitting Backed by pharmaceutical company Eli Lilly, Myriad obtained nine US patents in the mid-1990s on two genes -- -- strongly  ...
</description>
</item><item>
<title>FDA Rules In Favor Of Teva</title>
<link>http://www.inboxrobot.com/news.php?fid=199313598</link>
<pubDate>19 Nov 2008 20:55 GMT</pubDate>
<description>
...  lung cancer patients. The drug failed to meet the same goal when combined with Eli Lilly&#39;s Alimta and in a head-to-head study with Tarceva, which is made by ...
</description>
</item><item>
<title>Lilly Offers Free Health Guide, Available throughout State</title>
<link>http://www.inboxrobot.com/news.php?fid=199304800</link>
<pubDate>19 Nov 2008 20:16 GMT</pubDate>
<description>
... COLUMBUS, Ohio, Nov. 19 /PRNewswire/ -- Eli Lilly and Company recently unveiled a free pocket-sized health book, A Healthy You -- America&#39;s  ...
</description>
</item><item>
<title>Use of Antipsychotics in Children Is Criticized</title>
<link>http://www.inboxrobot.com/news.php?fid=199294989</link>
<pubDate>19 Nov 2008 19:19 GMT</pubDate>
<description>
...  of Risperdal and Zyprexa, popular antipsychotic medicines made, respectively, by Johnson &amp; Johnson and Eli Lilly &amp; Company. officials proposed that the committee endorse the agency&#39;s routine monitoring of the  ...
</description>
</item><item>
<title>UPDATE 4-AstraZeneca hit by double Pulmicort, Zact...</title>
<link>http://www.inboxrobot.com/news.php?fid=199292456</link>
<pubDate>19 Nov 2008 18:57 GMT</pubDate>
<description>
&gt; &gt; &gt; TFN News &gt; UPDATE 4-AstraZeneca hit by double Pulmicort, Zactima blow UPDATE 4-AstraZeneca hit by double Pulmicort, Zactima blow LONDON, Nov 19 (Reuters) - Anglo- ...
</description>
</item><item>
<title>ADHD Medication Not Found To Increase Genetic Damage</title>
<link>http://www.inboxrobot.com/news.php?fid=199285370</link>
<pubDate>19 Nov 2008 18:28 GMT</pubDate>
<description>
...  and Donald Mattison. Kollins has received funding and other support from Shire Pharmaceuticals, Pfizer, Eli Lilly, Psychogenics, New River Pharmaceuticals, Athenagen, and NIH. Dr. Chrisman has received honoraria from McNeil-PPC  ...
</description>
</item><item>
<title>Lilly and International Council of Nurses Win Partnership Award From the U.S. Chamber of Commerce Bu</title>
<link>http://www.inboxrobot.com/news.php?fid=199283798</link>
<pubDate>19 Nov 2008 18:20 GMT</pubDate>
<description>
...  honors Lilly and ICN&#39;s efforts to fight multidrug-resistant tuberculosis WASHINGTON, Nov. 19 /PRNewswire-FirstCall/ -- Eli Lilly and Company and the International Council of Nurses (ICN) won a Corporate Citizenship Award  ...
</description>
</item><item>
<title>AstraZeneca shares dip on mixed data from developing lung cancer drug, generic competition</title>
<link>http://www.inboxrobot.com/news.php?fid=199282742</link>
<pubDate>19 Nov 2008 18:10 GMT</pubDate>
<description>
...  cancer patients. But, the drug failed to meet the same goal when combined with Eli Lilly &amp; Co.&#39;s Alimta and in a head-to-head study with Tarceva, which is made by  ...
</description>
</item><item>
<title>AstraZeneca alters earnings forecast</title>
<link>http://www.inboxrobot.com/news.php?fid=199281413</link>
<pubDate>19 Nov 2008 18:07 GMT</pubDate>
<description>
The news coincided with the announcement of mixed results from AstraZeneca&#39;s late-stage trial for its lung cancer treatment Zactima on Wednesday, after which  ...
</description>
</item></channel>
</rss>
